English Innovation and reliability Start Company In vitro diagnostics Forensic identification Clinical analysis Quality Press room job Contact Start GENOMICA SAU GENOMICS: 25 YEARS AT THE SERVICE OF MOLECULAR DIAGNOSIS AND GENETIC IDENTIFICATION GENOMICA is the first Spanish company in Molecular Diagnosis and with great experience in carrying out Genetic Identification analyzes. Founded in 1990, it is located in the Community of Madrid. It is 100% owned by Pharma Mar (after the merger by absorption of Zeltia by Pharma Mar). Our mission is to improve the current methods of molecular diagnosis and genetic identification with reliable, automatic tools and according to the highest quality standards. Our main objective is to continue leading genomic applications in the Spanish market and to extend our activities internationally in the area of Molecular Diagnosis, through the design, development and commercialization of new diagnostic applications of our innovative Clinical Arrays Technology, CLART ® technological platform . GENOMICA has developed tests for the diagnosis of human papillomavirus associated with cervical cancer, for the diagnosis of respiratory viral diseases, detection of Human Herpes and Enteroviruses, as well as tests for the detection of human gene regions associated with the determination of response factors to therapies, specifically in the field of Oncology. Another field where GENOMICA bets strongly, is carrying out DNA analysis services in Legal and Forensic Medicine , and in Technology Transfer . Video: GENOMICA 25th Anniversary . CLART ® TECHNOLOGY NEDxA ® PATERNITY TESTS FOREIGN DNA TESTS News 2/6/2016 - 10 Years Accredited by ENAC 1/13/2016 - Agenda of International Fairs and Congresses for 2016 11/24/2015 - GENOMICA participates in Medica 2015 Events (edit) GENOMICA SAU Parque Empresarial Alvento, Building B Calle Vía de Los Poblados, 1 - 1st floor 28033 - Madrid (Spain) Telf .: +34 91 674 89 90 Fax: +34 91 674 89 91 LEGAL NOTICE COOKIES POLICY WEB MAP CONTACT Company associated with: Developed by Web4Bio